Study guide
8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC
Veterinary Technician Specialist in Emergency and Critical Care VTS ECC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment
1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions
2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR
2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism
3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance
3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders
4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation
4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics
5 Chapter 5: Gastrointestinal & Hepatic Emergencies
5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions
6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions
7 Chapter 7: Renal & Urinary Emergencies
7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation
8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS
8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies
9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles
10 Chapter 10: Neurological Emergencies
10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization
11 Chapter 11: Endocrine & Metabolic Crises
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
12 Chapter 12: Reproductive & Musculoskeletal Emergencies
12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation
13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20
13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist
8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC
Key Takeaways Explain This Topic AI
SIRS is the clinical syndrome of systemic dysregulated inflammation, while Sepsis is defined as SIRS resulting from documented or highly suspected infection accompanied by life-threatening organ dysfunction.
Canine and feline SIRS criteria differ substantially; cats classically exhibit a 'hypothermic, bradycardic, hypotensive' shock triad rather than the hyperdynamic tachycardia seen in dogs.
Septic shock represents sepsis with persistent hypotension (MAP <65 mmHg) despite adequate isotonic crystalloid resuscitation, requiring first-line vasopressor support with Norepinephrine (0.1–1.0 mcg/kg/min).
Disseminated Intravascular Coagulation (DIC) is an acquired consumptive coagulopathy characterized by widespread microvascular thrombin generation and simultaneous microvascular thrombosis and severe bleeding.
Definitive diagnosis of DIC requires a combination of prolonged coagulation times (PT/aPTT >25%), severe thrombocytopenia, elevated D-dimers/FDPs, decreased Antithrombin III (<60–70%), and the presence of schistocytes.
Last updated: August 2026
Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC
Systemic Inflammatory Response Syndrome ( SIRS ), Sepsis , and Disseminated Intravascular Coagulation ( DIC ) form a continuous spectrum of critical illness in veterinary emergency and critical care. When localized inflammation escapes physiological homeostatic control, widespread endothelial activation, cytokine release, microvascular thrombosis, and mitochondrial dysfunction culminate in Multiple Organ Dysfunction Syndrome (MODS) and death.
1. Defining SIRS, Sepsis, and Septic Shock
SIRS (Systemic Inflammatory Response Syndrome): The clinical manifestation of systemic, dysregulated immune activation triggered by infectious or severe non-infectious insults (e.g., severe acute pancreatitis, massive trauma, heatstroke, burn injury, or neoplasia).
Sepsis: SIRS caused by a confirmed or highly suspected infectious etiology (e.g., septic peritonitis, pyometra, pyothorax, severe pneumonia, bacterial endocarditis, or bite wound abscesses) resulting in acute, life-threatening organ dysfunction.
Septic Shock: A subset of sepsis in which profound circulatory, cellular, and metabolic abnormalities significantly increase mortality. Clinically defined as persistent arterial hypotension (Mean Arterial Pressure [MAP] < 65 mmHg <65\text{ mmHg} < 65 mmHg or Systolic Blood Pressure [SBP] < 90 mmHg <90\text{ mmHg} < 90 mmHg ) despite adequate intravascular fluid resuscitation , or hyperlactatemia ( > 2.0 mmol/L >2.0\text{ mmol/L} > 2.0 mmol/L ) requiring vasopressor therapy. [The Sepsis Continuum]
- ┌─────────────────────────────────────────────────────────────┐
- │ SIRS: Systemic Inflammatory Response (Non-Infectious/Infectious)│
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ SEPSIS: SIRS + Documented Infection + Organ Dysfunction │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ SEPTIC SHOCK: Sepsis + Refractory Hypotension (MAP <65) │
- │ Requiring Vasopressor Infusions │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ MODS / DIC: Multi-Organ Dysfunction & Consumptive Bleeding │
- └─────────────────────────────────────────────────────────────┘
- 2. Canine vs. Feline SIRS Diagnostic Criteria
Because feline cardiovascular and inflammatory physiology differs fundamentally from that of canines, distinct species-specific criteria must be applied:
| Parameter | Canine SIRS Criteria (Must meet ≥ 2 \ge 2 ≥ 2 of 4) | Feline SIRS Criteria (Must meet ≥ 2 \ge 2 ≥ 2 or 3 3 3 of 4) |
|---|---|---||
| Core Body Temperature | < 100.6 ∘ F <100.6^\circ\text{F} < 100. 6 ∘ F ( < 38.1 ∘ C <38.1^\circ\text{C} < 38. 1 ∘ C ) or > 102.6 ∘ F >102.6^\circ\text{F} > 102. 6 ∘ F ( > 39.2 ∘ C >39.2^\circ\text{C} > 39. 2 ∘ C ) | < 100.0 ∘ F <100.0^\circ\text{F} < 100. 0 ∘ F ( < 37.8 ∘ C <37.8^\circ\text{C} < 37. 8 ∘ C ) or > 104.0 ∘ F >104.0^\circ\text{F} > 104. 0 ∘ F ( > 40.0 ∘ C >40.0^\circ\text{C} > 40. 0 ∘ C ) |
| Heart Rate | > 120 beats/min >120\text{ beats/min} > 120 beats/min (Tachycardia) | < 140 beats/min <140\text{ beats/min} < 140 beats/min (Bradycardia) or > 225 beats/min >225\text{ beats/min} > 225 beats/min (Tachycardia) |
| Respiratory Rate | > 20 breaths/min >20\text{ breaths/min} > 20 breaths/min (or P aCO 2 < 30 mmHg P\text{aCO}_2 < 30\text{ mmHg} P aCO 2 < 30 mmHg ) | > 40 breaths/min >40\text{ breaths/min} > 40 breaths/min (or P aCO 2 < 30 mmHg P\text{aCO}_2 < 30\text{ mmHg} P aCO 2 < 30 mmHg ) |
| White Blood Cell Count (WBC) | < 6 , 000 / μ L <6,000/\mu\text{L} < 6 , 000/ μ L , > 16 , 000 / μ L >16,000/\mu\text{L} > 16 , 000/ μ L , or > 3 % >3\% > 3% band neutrophils | < 5 , 000 / μ L <5,000/\mu\text{L} < 5 , 000/ μ L , > 19 , 000 / μ L >19,000/\mu\text{L} > 19 , 000/ μ L , or > 5 % >5\% > 5% band neutrophils |
The Feline Septic Shock Triad: Hypothermic Bradycardia
In dogs, early sepsis classically manifests as hyperdynamic (warm) shock characterized by tachycardia, pyrexia, bright red (injected) mucous membranes, bounding pulses, and rapid CRT (<1 second).
Conversely, cats with sepsis classically present in hypodynamic (cold) shock , displaying the lethal feline triad: Hypothermia, Bradycardia ( < 140 bpm <140\text{ bpm} < 140 bpm ), and Severe Hypotension . Feline peripheral vessels fail to constrict appropriately during hypothermia, and endogenous opiate release and vagal stimulation suppress normal compensatory tachycardia. Warming a hypothermic, hypovolemic cat without prior volume resuscitation precipitates catastrophic vasodilation and cardiac arrest.
Loading diagram... SIRS to Septic Shock & DIC Pathophysiological Cascade
- 3. Resuscitation & Vasopressor Protocols in Septic Shock
- The Emergency Sepsis Bundle (Hour-1 Management)
Early Diagnostic Sampling: Collect blood cultures (aerobic and anaerobic), blood lactate, baseline CBC/biochemistry, and point-of-care ultrasound (AFAST/TFAST) prior to or immediately alongside antimicrobial administration.
Immediate Broad-Spectrum Bactericidal IV Antimicrobials: Administer within the first hour of admission. Typical empiric four-quadrant combinations include:
Ampicillin/Sulbactam ( 30 – 50 mg/kg IV q8h 30\text{–}50\text{ mg/kg IV q8h} 30 – 50 mg/kg IV q8h ) or Cefazolin ( 30 – 40 mg/kg IV q8h 30\text{–}40\text{ mg/kg IV q8h} 30 – 40 mg/kg IV q8h ) PLUS Enrofloxacin ( 10 – 15 mg/kg IV q24h 10\text{–}15\text{ mg/kg IV q24h} 10 – 15 mg/kg IV q24h in dogs; 5 mg/kg IV q24h 5\text{ mg/kg IV q24h} 5 mg/kg IV q24h in cats) or an aminoglycoside (Amikacin) if renal perfusion is preserved.
Add Metronidazole ( 10 – 15 mg/kg IV q12h 10\text{–}15\text{ mg/kg IV q12h} 10 – 15 mg/kg IV q12h ) if anaerobic coverage is not fully addressed.
Early Goal-Directed Crystalloid Resuscitation: Administer balanced isotonic crystalloids (Plasmalyte-A, Normosol-R, LRS) in rapid titrated aliquots ( 10 – 20 mL/kg 10\text{–}20\text{ mL/kg} 10 – 20 mL/kg in dogs; 5 – 10 mL/kg 5\text{–}10\text{ mL/kg} 5 – 10 mL/kg in cats ) over 15 minutes, evaluating dynamic responsiveness (lactate clearance, blood pressure, CRT, pulse quality).
Emergent Source Control: Drain infected effusions, debride necrotizing soft tissues, or perform emergency exploratory laparotomy (e.g., for septic peritonitis or pyometra) once cardiovascular parameters are stabilized.
Vasopressor & Inotropic Therapy in Refractory Septic Shock
When fluid resuscitation restores intravascular volume but arterial hypotension persists ( MAP < 65 mmHg <65\text{ mmHg} < 65 mmHg or SBP < 90 mmHg <90\text{ mmHg} < 90 mmHg ), vasopressor constant rate infusions (CRIs) must be initiated immediately via a central or secure peripheral line:
Norepinephrine (First-Line Vasopressor of Choice):
Dose: 0.1 to 1.0 mcg/kg/min IV CRI 0.1\text{ to }1.0\text{ mcg/kg/min IV CRI} 0.1 to 1.0 mcg/kg/min IV CRI (titrated to maintain MAP ≥ 65 mmHg \ge 65\text{ mmHg} ≥ 65 mmHg ).
Pharmacology: Potent α 1 \alpha_1 α 1 -adrenergic receptor agonist causing systemic vasoconstriction, with modest β 1 \beta_1 β 1 -inotropic support. Significantly superior to dopamine in reversing sepsis-induced vasodilation without inducing severe tachyarrhythmias.
Vasopressin (Second-Line / Adjunct Vasopressor):
Dose: 0.5 to 2.0 mU/kg/min 0.5\text{ to }2.0\text{ mU/kg/min} 0.5 to 2.0 mU/kg/min ( 0.0005 – 0.002 U/kg/min IV CRI 0.0005\text{–}0.002\text{ U/kg/min IV CRI} 0.0005 – 0.002 U/kg/min IV CRI ). Non-adrenergic V 1 V_1 V 1 vascular smooth muscle agonist; restores vascular tone in acidic, catecholamine-resistant vascular beds.
Dobutamine (Inotropic Agent):
Dose: 2.5 to 10 mcg/kg/min IV CRI 2.5\text{ to }10\text{ mcg/kg/min IV CRI} 2.5 to 10 mcg/kg/min IV CRI (Dogs); 1.0 to 5.0 mcg/kg/min 1.0\text{ to }5.0\text{ mcg/kg/min} 1.0 to 5.0 mcg/kg/min (Cats). β 1 \beta_1 β 1 -adrenergic agonist indicated when myocardial contractility is blunted despite restored MAP.
4. Disseminated Intravascular Coagulation (DIC)
Disseminated Intravascular Coagulation is not a primary disease but a catastrophic, acquired secondary syndrome characterized by systemic, unchecked activation of coagulation. Driven by massive tissue factor release and cytokine storm, DIC progresses through two distinct clinical phases: [Biphasic Evolution of DIC]
- PHASE 1: HYPERCOAGULABLE (NON-OVERT DIC) PHASE 2: HYPOCOAGULABLE (OVERT / CONSUMPTIVE DIC)
- Systemic microvascular fibrin deposition • Exhaustion of clotting factors & platelets
- Organ ischemia & micro-thrombi • Widespread hyperfibrinolysis
- ATIII consumed (<60-70%) • Spontaneous mucosal & cavitary bleeding
- Normal or minimally altered PT/aPTT • Markedly prolonged PT/aPTT (>25%)
- Subclinical, silent multi-organ damage • Schistocytes, severe thrombocytopenia
- The DIC Diagnostic Biomarker Panel
Because no single laboratory test confirms DIC, diagnosis requires satisfying at least 3 to 4 of the following diagnostic criteria in an at-risk patient:
Prolongation of Coagulation Times (PT and aPTT): Both Prothrombin Time (PT) and activated Partial Thromboplastin Time (aPTT) are prolonged by > 25 % >25\% > 25% above upper reference intervals , reflecting severe consumption of extrinsic, intrinsic, and common pathway coagulation factors.
Severe Thrombocytopenia: Progressive, severe decline in circulating platelet count (often < 50 , 000 – 100 , 000 / μ L <50,000\text{–}100,000/\mu\text{L} < 50 , 000 – 100 , 000/ μ L ) due to entrapment in widespread microvascular thrombi.
Schistocytes (RBC Fragmentation): Helmet cells and sheared erythrocyte fragments identified on peripheral blood smears, caused by mechanical bisection of red cells as they squeeze through fibrin-clogged capillaries.
Elevated D-Dimers and Fibrin Degradation Products (FDPs): High levels confirm both extensive thrombin-mediated fibrin clot formation and secondary plasmin-mediated fibrinolysis ( D -dimers > 500 ng/mL D\text{-dimers } >500\text{ ng/mL} D -dimers > 500 ng/mL or > 0.5 mcg/mL >0.5\text{ mcg/mL} > 0.5 mcg/mL ).
Depleted Antithrombin III (ATIII): ATIII activity drops below 60 – 70 % 60\text{–}70\% 60 – 70% (normal 80–120%) due to rapid consumption while binding active thrombin and loss through microvascular capillary permeability.
Hypofibrinogenemia: Fibrinogen concentration plunges in end-stage consumptive DIC as clotting substrate is exhausted.
Therapeutic Management of DIC
Treat the Underlying Primary Trigger: Eradicate sepsis (surgery, drainage, antibiotics), resect necrotic tissue, or stabilize severe pancreatitis.
Plasma Component Therapy: Administer Fresh Frozen Plasma (FFP: 10 – 20 mL/kg IV 10\text{–}20\text{ mL/kg IV} 10 – 20 mL/kg IV ) or Cryoprecipitate to replenish critical Antithrombin III, fibrinogen, and coagulation factors.
Anticoagulant Therapy (Heparin):
In the early hypercoagulable phase , Low-Molecular-Weight Heparin (Enoxaparin 0.8 – 1.0 mg/kg SC q8h 0.8\text{–}1.0\text{ mg/kg SC q8h} 0.8 – 1.0 mg/kg SC q8h ) or Unfractionated Heparin ( 100 – 200 U/kg SC q8h 100\text{–}200\text{ U/kg SC q8h} 100 – 200 U/kg SC q8h ) can halt microvascular thrombosis, provided adequate ATIII is present (heparin requires ATIII to exert its anticoagulant effect; co-administer with FFP if ATIII is depleted).
Heparin is strictly contraindicated in the end-stage, severely hemorrhaging hypocoagulable phase.